Biomarker evidence
Understand the biological question and the evidence behind candidate signals. Study what each measurement contributes to the complete panel.
Blood biomarkers. Read together.
Biomarker panels and specialist machine learning. A product family built one disease at a time, starting with lung.
Meet VarSee® Lung Available for research use
®Life leaves a pattern.
We’re learning to read it earlier.
VarSee is the product family being developed by BioMarkIQ. Our initial focus is lung cancer, where biomarker research and specialist machine learning come together around a specific disease question.
For research groups and laboratories, VarSee Lung is the starting point for a conversation about access, studies, and collaboration.
Explore VarSee LungUnderstand the biological question and the evidence behind candidate signals. Study what each measurement contributes to the complete panel.
Explore how a mixture-of-experts architecture can consider specialist outputs in context. Different specialists contribute different readings of the biological pattern.
Define the intended use, population, and comparison. Distinguish model development from independent and combined-system evaluation.
Multi-cancer early detection is a broader development ambition. Connecting disease programs introduces new questions about performance, follow-up, and usefulness in the intended population.
Understand the MCED approach